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Two human squamous carcinoma cell lines and human 
diploid fibroblasts were examined for the production of 
extracellular matrix (ECM) molecules including fibro- 
nectin (FN), laminin (LN), and thrombospondin (TSP) 
when grown on a number of different substrates. The 
substrates used included glass, plastic, collagen (gela- 
tin), and DEAE-dextran. Levels of TSP as indicated by 
enzyme-linked immunosorbent assay d id  not vary 
significantly as a function of substrate. In contrast, 
LN levels in  the culture medium were significantly 
decreased when the cells were grown on DEAE-dextran 
or collagen-linked dextran as compared to the other 
substrates. FN levels were slightly lower in the culture 
medium of the cells grown on DEAE-dextran. Biosyn- 
thetic labeling followed by immunoprecipitation indi- 
cated that the reduction in  LN was due, in  part, to  
decreased biosynthesis. Previous studies have indicated 
that LN influences the behavior of epithelial cells in cul- 
ture and that the cells, themselves, are a major source 
of the LN. The differences in LN production noted here 
indicate that the production of this ECM component is 
influenced by the substratum on which the cells are 
grown. These differences could contribute to alterations 
in biological properties that are known to be influenced 
by the substratum. 
INTRODUCTION 
Cell -cell and cell - substrate adhesion are critical to 
several biological processes including fertilization, embryo- 
genesis, inflammation, wound healing, and tumor cell 
invasion. ' In addition to these in vivo processes, cultivation 
of most higher eukaryotic (anchorage-dependent) cells in 
vitro also requires adhesion to a substratum. Anchorage- 
dependent cells do not attach directly to the substratum, 
but rather, attach and spread on an extracellular matrix 
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(ECM), which is deposited onto the substratum. Compo- 
nents of the extracellular matrix include collagens of vari- 
ous types, soluble glyoproteins such as fibronectin (FN), 
laminin (LN), and thrombospondin (TSP) and proteogly- 
cans such as heparan sulfate pr~teoglycan.~ '~ '~ While serum 
used in the culture medium may provide most of the FN 
initially deposited onto the substrate,' the cells, themselves, 
are responsible for synthesizing FN and the other glyco- 
protein components of the matrix .6-17 The endogenously- 
synthesized matrix components are secreted by the cells 
and incorporated into the developing matrix. The cells that 
produce the ECM molecules also express surface receptors 
for these components and interact with the matrix via these 
receptors. Recent studies have shown that the continued 
adhesion of cells to the substratum-as well as their pro- 
liferation - is dependent on endogenousiy-produced matrix 
 molecule^.^*.^^ In the present study, the production of ECM 
molecules by cells grown on a number of different sub- 
strates was examined. The authors report here that there 
are significant substrate-dependent differences in the produc- 
tion of glycoprotein components of the ECM by anchorage- 
dependent cells. These differences in ECM production may 
contribute to the alterations in properties which occur when 
the substrate on which the cells are grown is changed.3G32 
MATERIALS AND METHODS 
Cells 
Two human squamous carcinoma cell lines, designated 
as UM-SCC-1 and UM-SCC-11B, were used in these stud- 
ies. The isolation and characterization of these lines have 
been described previ~us ly .~~ In the present study the cells 
were grown at 37°C and 5% CO,. The growth medium 
was Minimal Essential Medium of Eagle with Earle's 
CCC 0006-3592/89/01001235-007$04.00 
salts (MEM) supplemented with 15% fetal bovine serum, 
nonessential amino acids, 100 U per mL of penicillin and 
100 p g  per mL of streptomycin. The cells were subcul- 
tured by trypsinization as required. In certain experiments 
human diploid (foreskin) fibroblasts were used. The fi- 
broblasts were grown in MEM supplemented with 10% fe- 
tal bovine serum and used at between passage 1 and 15. 
Substrates and Culture Conditions 
Six different substrates (all in microcamer form) were 
used in these studies. These include microcarriers made of 
DEAE-dextran (Cytodex I) and collagen-linked dextran 
(Cytodex III), both obtained from Pharmacia (Piscataway, 
NJ); collagen (Ventregel) from Ventrex Laboratories (Port- 
land, ME), glass-coated (Biosil) and collagen-coated poly- 
styrene plastic (SoloHill Engineering, Ann Arbor, MI) and 
polystyrene plastic (Biosilon) from GIBCO, (Grand Island, 
NY). Denatured pig skin type I collagen (gelatin) is the 
collagenous component in each of the collagen-containing 
substrates. Each substrate was prepared for use according 
to the recommendations of the respective manufacturer. 
Cultures were established in 35 mm bacteriological dishes 
using a sufficient amount of each substrate to provide ap- 
proximately 30 cm2 of surface area. Cells were harvested 
from monolayer culture, diluted to contain 7.5 X lo5 cells 
in 2 mL of culture medium and mixed with the microcani- 
ers. The cultures were then incubated for 18-24 hours at 
37°C and 5% CO,. Following incubation, the cells were 
washed four times in serum-free culture medium and incu- 
bated for an additional period of time in MEM containing 
10% fetal bovine serum or in serum-free MEM containing 
200 p g  of bovine serum albumin (BSA)/mL. This culture 
medium was then harvested, separated from cells and micro- 
carriers by centrifugation, and assayed for immunoreactive 
FN, LN or TSP as described below. The cells were then 
harvested and counted using a nuclei assay procedure.34 
Extracellular Matrix Molecules 
The ECM molecules utilized in these experiments in- 
cluded FN, TSP, and LN. Each was obtained and charac- 
terized as previously de~cribed.~’ Briefly, human plasma 
FN was obtained from GIBCO. When examined by so- 
dium dodecylsulfate-polyacrylamide gel electrophoresis 
(SDS-PAGE) under reducing conditions, a single band at 
M, = 200 kD was seen. FN reacted with monospecific 
polyclonal rabbit anti-FN antibodies (Accurate Scientific 
and Chemical Co., Westbury, NY) at dilutions up to 1 : lo6 
in enzyme-linked immunosorbent assay (ELISA) but did 
not react with anti-LN antibodies or anti-TSP antibodies. 
TSP was purified in the laboratory from outdated human 
plasma using Heparin-Sepharose affinity chromatogra- 
phy. 36 The purified TSP migrated on SDS-polyacrylamide 
gels as a single band with a M, = 180 kD under reduc- 
ing conditions. It reacted with rabbit anti-TSP antibodies 
(1 : 1-1 : lo6 dilutions) in ELISA but did not react with 
anti-FN or anti-LN antibodies. LN was prepared from the 
Englebreth-Holm-Swarm (EHS) tumor by the method of 
Timpl et al.37 When examined by SDS-PAGE under reduc- 
ing conditions, protein bands at M, = 200 kD and 400 kD 
were seen. The laminin reacted by ELISA with mono- 
specific polyclonal antil-LN antibodies at dilutions up to 
1 : lo6 but did not react with antibodies to TSP or FN. In 
some experiments, commercially available LN (Collaborative 
Research, Boston MA) was also used with similar results. 
Rabbit polyclonal antibodies (whole sera or gamma 
globulin fractions of whole sera) to each of the ECM com- 
ponents were also used in these studies. These were ob- 
tained and characterized as described previo~sly.~’ Each 
antibody reacted with its appropriate antigen in ELISA but 
showed no cross-reactivity with the other ECM compo- 
nents. Normal rabbit serum or globulin was used as a control. 
LN and TSP purified as described above were iodinated 
using immobilized chloramine T on nonporous polystyrene 
beads (Iodo-Beads, Pierce Chemical Co., Rockford, IL). 
The protein iodinations were done by Dr. James Smart 
(Department of Pathology, University of Michigan). Free 
iodide was removed by filtration on a Sephadex G25 
column. ‘251-LN and Iz5I-TSP with specific activities of 
1-2 pCi/pg were obtained. These values are similar to 
what we have reported previously.24325 Both proteins retained 
most of their biological activity (i.e., ability to induce cell- 
substrate adhesion of appropriate cells) after iodination. 
The iodinated proteins were used to assess LN and TSP 
adsorption to the various substrates. 
Enzyme-Linked lmmunosorbent Assay (ELSA) 
ELISAs were used to quantitate the amount of immuno- 
reactive FN, LN, or TSP present in the culture fluids of 
the cells. After clarification by centrifugation, the culture 
fluids prepared as described above were added in duplicate 
(0.1 mL per well) to wells of a 96-well plate (Falcon Plas- 
tics; Oxnard, CA). The plates were chosen from lots that 
had been preselected for acceptibility in ELISA. The cul- 
ture fluids were incubated in the wells for 4 hours at 37°C. 
Control culture medium which had been preincubated along 
with the cells served as the control. Purified FN, LN, or 
TSP (0.1-0.0001 pg  per well) were incubated in the same 
medium to serve as a standard. After the 4-hour incuba- 
tion, the supernatant fluids from the cells and the control 
fluids were removed from the assay plate and the ELISAs 
were carried out as described previou~ly .~~ 
Biosynthetic Labeling 
Cells were grown on the various substrates as described 
above and 6-7 cultures were pooled to provide approxi- 
mately 5 X lo6 cells in a 100 mm culture dish. The cells 
were washed and incubated for 30 minutes in methionine- 
free, serum-free MEM (Flow Laboratories; McLean, VA) 
followed by a 60-minute incubation in the same medium 
supplemented with 100 pCi per dish of 35S-methionine 
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(1000- 1400 pCi/pmole; NEN, Boston, MA). After the 
60-minute biosynthetic pulse, the cells were lysed in a so- 
lution of phosphate-buffered saline (PBS) containing three 
detergents (1% Triton X-100, 0.5% sodium deoxycholate 
and 0.1% SDS; all obtained from Sigma Chemical Co.) 
and protease inhibitors including 20mM EDTA, 5mM 
N-ethyl maleimide, 2mM phenylmethysulfonyl fluoride 
and 10 pL/ 10 mL of a protease inhibitor cocktail contain- 
ing: leupeptin, 1 mg/mL; antipain, 2 mg/mL; benzami- 
dine, 10 mg/mL; aprotinin, 10,OOO kallikrein-inactivating 
units/mL; chymostatin, 1 mg/mL; and pepstatin, 1 mg/mL, 
as described by Ronnett et al.39 in studies on the insulin 
receptor. All of the protease inhibitors were obtained from 
Sigma Chemical Co. The cell lysates were frozen at -8OoC, 
thawed, and clarified by ultracentrifugation (37000 g for 
60 min). Immunoreactive LN or TSP was precipitated with 
a 1 : 100 dilution of the rabbit anti-LN or anti-TSP and Pro- 
tein A-Sepharose (Sigma Chemical Co.) according to the 
protocol of Ruddon et a1.40 Normal rabbit serum served as 
a control. The washed immunoprecipitates were eluted with 
boiling (5 min) in twofold concentrated Laemmli SDS- 
PAGE sample buffer4' containing 2% 2-mercaptoethanol. 
The immunoprecipitated material was fractionated on a 
3- 10% polyacrylamide get employing the LaemmIi system. 
Radioactive bands were visualized by fluorography with 
En3Hance (NEN), exposing the dried gels to X-ray film 
(Kodak XAR-2) for two days. Additionally, samples of the 
immunoprecipitates were counted directly for total radioac- 
tivity and compared to the amount of radioactivity in the 
original cell lysates precipitated with 10% (final) trichloro- 
acetic acid. 
RESULTS 
Quantitation of FN, LN, and TSP in the Culture 
Fluid by ELSA 
ELISAs were used to quantitate the amount of FN, LN, 
and TSP released into the culture fluids by cells grown on 
the different substrates. Cells were plated on the various 
substrates at 7.5 X lo5 cells per group as described in the 
Materials and Methods section. After incubation for one 
day, the culture medium was removed. The cells were then 
washed four times with serum-free MEM and incubated 
for an additional two hours or 24 hours with 2 mL of 
MEM supplemented with 200 p g  of BSA/mL. The culture 
fluids were then harvested and assayed for immunoreactive 
FN, LN, and TSP. The cells were harvested and counted. 
Data from the UM-SCC-11B cells on six different sub- 
strates are shown in Table I. Data from the other squamous 
carcinoma line and the normal fibroblasts are shown in 
Table 11. It can be seen that the amount of TSP recovered 
from the culture fluids varied only slightly as a function of 
the substrate on which the cells were grown. In contrast, 
the amount of LN recovered from the culture medium was 
dramatically lower when the cells were cultured on the 
DEAE-dextran and collagen-linked dextran substrates rela- 
Table I. 
SCC-113 cells grown on various substrates. 
Immunoreactive LN, FN, and TSP in the culture fluid of UM- 
Immunoreactive LN, FN, or TSP 
(ng/mL/l x I O ~  
Substrate' LN FN TSP 
Plastic (2 hours) 
Glass (2 hours) 
Collagen (2 hours) 
Collagencoated plastic (2 hours) 
Collagen-linked dextran (2 hours) 
DEAE-dextran (2 hours) 
Collagen-coated plastic (24 hours) 
DEAE-dextran (24 hours) 
8 0 2  16 1420 2 85 
64 2 10 1600 t 90 
68 t 4 1170 2 150 
60 t 8 1630 2 50 
4 2  2 11502 25 
2 2 1 1250 2 35 
238 t 10 Not done 
20 2 5 Not done 
195 ? 35 
330 t 10 
180 t 45 
445 t 35 
300 2 60 
350 t 50 
Not done 
Not done 
a Each substrate was prepared as described in the Matenals and Meth- 
ods section and inoculated with 7.5 X lo5 cells in 2-mL cultures (35-mm 
bacteriological dishes). After incubation for one day the culture medium 
was removed and the cultures washed four times. Two mL of MEM sup- 
plemented with Mo pg of BSA/mL were added to each dish and the cells 
incubated for an additional two or 24 hours. The culture fluids were then 
harvested and analyzed for immunoreactive LN, FN, or TSP using 
ELISAs. Values were obtained directly from standard curves. After re- 
moving the culture fluid, cell numbers on each substrate were determined 
using a nuclei assay. 
Values represent average ng of immunoreactive matenal 2 the differ- 
ences between individual values and averages based on duplicate samples 
in a single experiment. The experiment was repeated three times with 
similar results. 
tive to the others and the amount of FN recovered was 
slightly lower under the same conditions. 
In an additional set of experiments, ELISAs were used 
to quantitate the amount of LN released into the culture 
medium by UM-SCC-11B cells in the presence of serum. 
The cells were grown on collagen-coated plastic and on 
DEAE-dextran for periods of time ranging from 1-5 days. 
After incubation, the culture medium was removed and the 
cells were washed four times with serum-free MEM. The 
cells were then incubated for an additional two hours or 
24 hours in MEM supplemented with 10% fetal bovine 
serum. The culture fluids were harvested and assayed for 
immunoreactive LN. Substrate-dependent differences in 
the serum-containing culture medium were even greater 
than the differences observed under serum-free conditions. 
In the 2-hour culture fluid from the cells grown on collagen- 
coated plastic, there was approximately 360 ng of immuno- 
reactive LN per culture as compared to 5 ng in the culture 
fluid from the cells grown on DEAE-dextran. At 24 hours, 
there was approximately 2000 ng of immunoreactive mate- 
rial in the culture fluid from the cells grown on collagen- 
coated plastic as compared to 22 ng in the culture fluid 
from the cells grown on DEAE-dextran (Fig. 1). These 
substrate-dependent differences remained over time. UM- 
SCC-11B cells grown for up to five days on the same sub- 
strates produced comparable amounts of immunoreactive 
LN per 24-hour period as the amounts shown in Figure 1 
(not shown). 
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Table 11. Immunoreactive LN and FN in the culture fluid of cells grown on various substrates. 
2000 
1000 
5 0 0  
Cell typea 
Immunoreactive LN or FN 
(ng/mL/1 x lo6 
Substrate LN FN 
UM-SCC- 1 plastic 
(squamous carcinoma) glass 
collagen-coated plastic 
DEAE-dextran 




53 + 2 
6 0 * 4  
57 2 8 
6 + 3  
65 5 5 
6 0 + 8  
Not done 
10 + 5 
1150 4 20 
1500 2 15 
1485 * 70 
1040 2 70 
1005 2 100 
1300 + 150 
Not done 
500 * 55 
a Each substrate was prepared as described in the Materials and Methods section and inoculated 
with 7.5 X 10' cells in 2-mL cultures (35-mm bacteriological dishes). After incubation for one day 
the culture medium was removed and the cultures washed four times. Two mL of MEM supple- 
mented with 200 p g  of BSA/mL were added to each dish and the cells incubated for an additional 
two hours. The 2-hour culture fluids were then harvested and analyzed for immunoreactive LN or 
FN using ELISAs. Values were obtained directly from standard curves. After removing the culture 
fluid, cell numbers on each substrate were determined using a nuclei assay. 
Values represent average ng of immunoreactive material 2 the differences between individual 
values and averages based on duplicate samples in a single experiment. Each cell type was exam- 
ined two times with similar results. 
Collagen-coated 
DEAE-dextran 
2 hours 20 hour8 
Figure 1. Immunoreactive LN in the culture fluid of UM-SCC-IIB 
cells grown on collagen-coated plastic and DEAE-dextran. The substrates 
were prepared as described in the Materials and Methods section and in- 
oculated with 7.5 X lo5 cells in 2-mL cultures. After incubation for one 
day the culture medium was removed and the cultures washed four times. 
Two mL of MEM supplemented with 10% fetal bovine serum were added 
to each dish and the cells incubated for an additional two or 24 hours. 
The culture fluids were then harvested and analyzed for immunoreactive 
LN using ELISAs. Values were obtained directly from standard curves. 
After removing the culture fluids, cell numbers were determined using a 
nuclei assay. Values shown represent average ng of immunoreactive ma- 
terial t the differences between individual values and averages based on 
duplicate samples in a single experiment. The experiment was repeated 
three times with similar results. 
First, cells grown on DEAE-dextran and cells grown on 
collagen-coated plastic were compared for LN and TSP 
biosynthesis. UM-SCC-11B cells grown on the two 
substrates were labeled with 35S-methionine for one 
hour as described in the Methods section. Extracts were 
prepared from the labeled cells and examined for total 
"S-methionine incorporation into trichloroacetic acid- 
precipitable material and into anti-LN and anti-TSP pre- 
cipitable material. Total protein synthesis was reduced 
slightly (approximately 34% based on differences in iso- 
tope incorporation) in the cells grown on DEAE-dextran as 
compared to the cells grown on collagen-coated plastic. As 
a fraction of total protein synthesized, there was no differ- 
ence in TSP biosynthesis between the cells on the two sub- 
strates (Table 111). In contrast, laminin biosynthesis was 
reduced by approximately 67% in the cells grown on DEAE- 
Table 111. 
collagen-coated plastic and DEAE-dextran." 
LN and TSP biosynthesis by UM-SCC-I1B cells grown on 
Immunoreactive LN or TSP 
(% of total proteinlb 
Substrate LN TSP 
Collagen-coated plastic 0.31 0.05 0.58 * 0.10 
DEAE-dextran 0.13 + 0.02 0.50 + 0.05 
Biosynthetic Labeling 
The reduction in immunoreactive LN in the culture fluid 
of the cells grown on DEAE-dextran and collagen-linked 
dextran as compared to the other substrates could result 
from decreased biosynthesis. Alternatively, a higher rate of 
adsorption of the LN to the DEAE-dextran and collagen- 
linked dextran could account for the observed difference. 
A number of experiments were done to address this issue. 
a Cells grown on the two substrates were examined for LN and TSP 
biosynthesis using "S-methionine incorporation into protein followed by 
detergent extraction and immunoprecipitation. 
Samples of each cell lysate were precipitated with 10% trichloroacetic 
acid (TCA) to obtain total CPM of 35S-methionine incorporated into pro- 
tein. Samples of the same lysates were immunoprecipitated with antibod- 
ies to LN or TSP. The ratios of CPM in the immunoprecipitates to 
TCA-precipitable CPM were determined. The values shown are based on 
a single experiment. This experiment was repeated three times with simi- 
lar results. 
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Figure 2. Biosynthesis of LN and TSP by UM-SCC-IIB cells. Cells were examined for ECM component biosyn- 
thesis by "S-methionine incorporation into protein followed by immuno-precipitation, SDS-PAGE and autoradiogra- 
phy. A 3-10% gradient gel was used and the samples were electrophoresced in the presence of 2% 2- 
mercaptoethanal. The molecular profile of LN is shown in the left-side figure. A single protein band at 400 kDa and 
a doublet at 200 kDa are seen. Lane A, DEAE-dextrdanti-LN; Lane B, DEAE-dextranlnormal rabbit serum; Lane 
C, collagen-coated plastic/normal rabbit serum; Lane D, collagen-coated plasticianti-LN. The molecular profile of 
TSP is shown in the right-side figure. A single protein band at 180 kDa is seen. Lane A, DEAE-dextranianti-TSP; 
Lane B, collagen-coated plastic/anti-TSP 
dextran as compared to cells grown on collagen-coated 
plastic (Table 111). In spite of the quantitative differences, 
there appeared to be no significant difference in the mo- 
lecular forms of either LN or TSP as a function of sub- 
strate (Fig. 2 ) .  
LN and TSP Adsorption to Different Substrates 
DEAE-dextran, glass, and collagen-coated plastic sub- 
strates were incubated with serum-containing culture me- 
dium (without cells) for one day. Following this, they 
were washed four times in serum-free culture medium and 
incubated for two hours in MEM containing 200 pg  of 
BSA/mL and iodinated LN or TSP (1 pg  per reaction). At 
the end of the incubation period, the amounts of LN and 
TSP bound to each substrate were determined. Under the 
conditions of the assay, there was no significant difference 
in LN adsorption to the different substrates (Fig. 3). Like- 
wise, there was no difference in TSP binding to the 
collagen-coated plastic microcarriers and DEAE-dextran 
microcarriers (not shown). 
DISCUSSION 
ECM components, especially LN, play critical roles in 
adhesion, motility, proliferation, and differentiation of 
4.0 6 
0 1  I I 
0 1 2 3 
NUMBER OF WASHES 
Figure 3. Adsorption of '"I-LN to various substrates. The substrates 
were incubated in MEM containing 10% fetal bovine serum for one day 
at 37°C. Following this, they were washed four times in serum-free MEM 
and incubated for two hours in MEM supplemented with 200 p g  of 
BSA/mL with 1 p g  of LN (1 X lo6 cpm). Following the 2-hour incuba- 
tion, the substrates were separated from the incubation medium by cen- 
trifugation. The radioactivity remaining associated with each substrate 
was determined after 1, 2,  or 3 washes. Values represent means * 
standard deviations based on four samples in a single experiment. The ex- 
periment was repeated three times with similar results. (Collagen-coated 
plastic, 0-0; DEAE-dextran, A-A; glass, 0-0). 
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anchorage-dependent epithelial cells in vitro (see refer- 
ences 42 and 43 for reviews). The molecular basis for 
these effects are not fully understood. A number of differ- 
ent types of cells express specific receptors for LN (20- 
24). It has been shown with murine fibrosarcoma cells that 
LN receptors are directly linked to the cytoskeleton and 
that binding of LN to these receptors induces cytoskeletal 
reorganization.44 It has also been shown that LN induces 
the release of arachidonic acid from phospholipid pools in 
murine fibrosarcoma cells and that this results in produc- 
tion of both lipooxygenase and cylooxygenase metabolites 
from arachidonic These metabolites are themselves 
potent intermediaries in a variety of biological events. 
Unlike FN, LN is not found in significant quantities in 
plasma.42 Therefore, it is not present in the serum used 
routinely for in vitro cultivation of cells. However, since 
most cells are capable of biosynthesizing LN (8-12), they 
are capable of producing necessary amounts of LN for in 
vitro growth and for other functions that depend on LN. 
Studies from the authors' and from other 
lab~ra tor ies"~ '~*~~ have provided strong evidence to indicate 
that cell adhesion in vitro is mediated, in part, through 
endogenously-produced LN. Because of its significance to 
biological behavior, how LN production is regulated and 
how endogenously-produced LN influences cell behavior 
are of interest. The influence of the substratum on the 
production of LN by human cells is the subject of this re- 
port. Here it is shown that LN production by two different 
squamous carcinoma cell lines and by diploid fibroblasts 
is dramatically decreased when the cells are grown on 
DEAE-dextran or collagen-linked dextran as compared to 
several other substrates. The amount of LN in the culture 
fluid of the cells grown on DEAE-dextran is decreased by 
up to 99% as indicated by ELISA. FN production is also 
inhibited on the same substrate although to a much smaller 
degree. In contrast, TSP production vanes only slightly 
with the substrate. 
The cellular and molecular basis for the substrate- 
dependent differences in LN production are not understood 
at present. In part, they appear to be due to altered biosyn- 
thesis. Biosynthetic labeling and immunoprecipitation indi- 
cated an approximately 67% reduction in LN synthesis by 
cells grown on DEAE-dextran during a 1-hour pulse rela- 
tive to total protein synthesis. This was in addition to an 
overall reduction in protein synthesis of approximately 
34% on the same substrate. 
Altered capacity of the different substrates to bind se- 
creted LN could also account for the reduction seen on the 
DEAE-dextran substrate. It might be expected, in fact, that 
the highly-charged DEAE-dextran molecole would be 
more effective at binding secreted proteins than the other 
substrates. Attempts to demonstrate this, however, with io- 
dinated LN did not support this. When the DEAE-dextran 
substrate was compared to collagen-coated plastic for LN 
or TSP binding under conditions that mimicked those em- 
ployed with cells, virtually identical amounts of both ECM 
components were absorbed by the two substrates. 
Another possibility is that there are substrate-dependent 
differences in proteolysis which contribute to altered LN 
levels. In a previous study it was shown that normal hu- 
man fibroblasts grown on DEAE-dextran produced much 
higher levels of fibrinolytic activity than the same cells 
grown on glass or plastic.31 Significant amounts of both 
urokinase type plasminogen activator (u-PA) and tissue 
type plasminogen activator (t-PA) were detected in the cul- 
ture fluid of cells on DEAE-dextran while only u-PA was 
seen when the cells were grown on glass. That differential 
proteolysis might account for the differences in LN pro- 
duction is an especially attractive idea since it has been 
shown that LN binds to both plasminogen and t-PA.& This 
possibility has yet to be examined systematically. How- 
ever, this is not likely to be the entire explanation because 
analysis by SDS-PAGE did not reveal any unique fragmen- 
tation pattern in the lysates from the DEAE-dextran grown 
cells. If increased proteolysis were responsible for the de- 
creased amounts of LN detected, one might expect to 
see fragments on SDS-polyacrylamide gels. Regardless of 
mechanism, the substrate-dependent differences observed 
here could have biological relevance. The well-described 
differences in cell-substrate adhesion, growth rates, and 
morphology between cells grown on DEAE-dextran and on 
glass or could be a reflection, in part, of differ- 
ences in matrix molecule production and utilization. 
This study was supported in part by grant CA43352 from the 
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